Six Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):718-721. doi: 10.1016/j.ijrobp.2016.11.038.

Authors

Justin E Bekelman¹, W Robert Lee²

Affiliations

¹ Departments of Radiation Oncology and Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: bekelman@uphs.upenn.edu.
² Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina.

PMID: 28244406
DOI: 10.1016/j.ijrobp.2016.11.038

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Male
Prostatic Neoplasms*

Grants and funding

K07 CA163616/CA/NCI NIH HHS/United States